ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
66 hedge funds and large institutions have $117M invested in ChemoCentryx, Inc. in 2013 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 30 increasing their positions, 14 reducing their positions, and 15 closing their positions.
114% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 14
2% more funds holding
Funds holding: 65 → 66 (+1)
7% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 15
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
57% less capital invested
Capital invested by funds: $273M → $117M (-$156M)
72% less call options, than puts
Call options by funds: $419K | Put options by funds: $1.51M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$32.9M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$11.5M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$5.22M |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$3.79M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$3.46M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$30.4M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$9.5M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$3.61M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.64M |
| 5 |
JP Morgan Chase
New York
|
-$2.51M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Schroder Investment Management Group
London,
United Kingdom
| – | -$215K | -15,214 | Closed |
|
77
BNP Paribas Financial Markets
Paris,
France
| – | -$144K | -10,218 | Closed |
|
|
JG
78
Jefferies Group
New York
| – | -$144K | -10,198 | Closed |
|
|
SFPIA
79
Stevens First Principles Investment Advisors
Newport Beach,
California
| – | -$14K | -1,000 | Closed |
|
|
SSG
80
Summit Securities Group
New York
| – | -$4K | -300 | Closed |
|
CCXI Hedge Fund Activity: Q3 2013 in Review
66 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q3 2013, worth a combined $117M — down 57% from $273M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new CCXI positions and 15 closed out — a net gain of 1 holder — while 30 added to existing stakes and 14 trimmed.
The largest buyer was RA Capital Management, opening a new position worth an estimated $32.9M. The largest seller was Jennison Associates, exiting entirely with an estimated $30.4M sold.
- 66 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q3 2013, up from 65 in Q2 2013.
- Funds reported $117M of ChemoCentryx, Inc. stock for Q3 2013, down 57% quarter-over-quarter.
- 16 funds opened new ChemoCentryx, Inc. positions in Q3 2013 and 15 closed out, a net change of +1 holder.
- The largest ChemoCentryx, Inc. buyer in Q3 2013 was RA Capital Management, an estimated $32.9M added.
- The largest ChemoCentryx, Inc. seller in Q3 2013 was Jennison Associates, an estimated $30.4M sold.
Based on aggregated 13F filings for Q3 2013.